Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Neuroblastoma
Related studies linked through entity extraction aliases.
Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Therapy for Children With Advanced Stage High Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- NA
Therapy for Children With Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Campath-1H + FK506 and Methylprednisolone for GVHD
- Status
- COMPLETED
- Phase
- PHASE2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- Status
- RECRUITING
- Phase
- PHASE2
Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma
- Status
- UNKNOWN
- Phase
- PHASE1
Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
- Status
- UNKNOWN
- Phase
- PHASE2
N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1